anmelden
SPI
18.478,60
PKT
+85,72
PKT
+0,47
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.10.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 10.10.12 | Julius Bär buy | Nomura | |
| 10.10.12 | Sulzer buy | UBS AG | |
| 10.10.12 | Givaudan equal-weight | Morgan Stanley | |
| 10.10.12 | EMS-CHEMIE hold | Vontobel Research | |
| 10.10.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 10.10.12 | EMS-CHEMIE buy | Sarasin Research | |
| 10.10.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 10.10.12 | Implenia buy | Vontobel Research | |
| 10.10.12 | Forbo International buy | Vontobel Research | |
| 10.10.12 | ams-OSRAM buy | Vontobel Research | |
| 10.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 09.10.12 | Givaudan reduce | Nomura | |
| 09.10.12 | ABB (Asea Brown Boveri) underperform | Cheuvreux SA | |
| 09.10.12 | Kühne + Nagel International buy | Nomura | |
| 09.10.12 | Julius Bär buy | Sarasin Research | |
| 09.10.12 | Givaudan neutral | Sarasin Research | |
| 09.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Forbo International buy | Vontobel Research | |
| 09.10.12 | Holcim outperform | Sanford C. Bernstein and Co., Inc. | |
| 08.10.12 | Novartis halten | Independent Research GmbH | |
| 08.10.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 08.10.12 | Ascom buy | UBS AG | |
| 08.10.12 | Novartis reduce | Vontobel Research | |
| 08.10.12 | Swatch (I) neutral | J.P. Morgan Cazenove | |
| 05.10.12 | Clariant buy | UBS AG | |
| 05.10.12 | Givaudan neutral | UBS AG | |
| 05.10.12 | Lonza hold | Vontobel Research | |
| 05.10.12 | Arbonia hold | Vontobel Research | |
| 05.10.12 | Swiss Re neutral | Sarasin Research | |
| 05.10.12 | Sonova neutral | Sarasin Research | |
| 05.10.12 | Roche kaufen | Fuchsbriefe | |
| 05.10.12 | Straumann hold | Vontobel Research | |
| 05.10.12 | Sonova buy | Vontobel Research | |
| 04.10.12 | Novartis buy | Nomura | |
| 04.10.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 04.10.12 | Roche outperform | Cheuvreux SA | |
| 04.10.12 | Givaudan neutral | Credit Suisse Group | |
| 04.10.12 | Nestlé neutral | Citigroup Corp. |